{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Cardiac Exchange","title":"Durability and Lifetime Management of the Avalus™ Platform","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/97f818e1\"></iframe>","width":"100%","height":180,"duration":2734,"description":"Professor Kappetein sits down with Mr Dincer Aktuerk of Barts Heart Center in London, United Kingdom and Professor Robert Klautz of Leiden University Medical Center, Netherlands to discuss the clinical data from the PERIGON Study. This discussion covers a variety of topics including the importance of data when treating patients, with a focus on lifetime management and durability of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) surgeries.11. Sabik JF III, Rao V, Dagenais F, et al. 7-Year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicenter analysis. Eur J Cardiothorac Surg. 2024;67(1):ezae414. doi:10.1093/ejcts/ezae414.Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.See Avalus™ Bioprosthesis risk information: https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/heart-valves/tissue-valves-conduits/avalus-bioprosthesis.html?sheet=open ","thumbnail_url":"https://img.transistorcdn.com/gbC6yhQUVau7iz96Bhh3xNVLsQz1yGN44oHkHqlB6nw/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzIzMzMzLzE2MzA1/MTM0OTgtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}